Metabolic Mysteries: The Role of Copper Dysregulation in Liver Disease
Contents
Chair
Prof. Ralf Weiskirchen
The head of the Institute of Molecular Pathobiochemistry, Experimental Gene Therapy, and Clinical Chemistry (IFMPEGKC) at the RWTH University Hospital Aachen, Germany
Speaker(s)
Prof. Wolfgang Stremmel
Medical Center Baden-Baden, Baden-Baden, Germany
Topic: Pathophysiology of Copper Metabolism in Wilson Disease
Topic: Pathophysiology of Copper Metabolism in Wilson Disease
Prof. Kay L Double
Brain and Mind Centre and School of Medical Sciences (Neuroscience), The University of Sydney, Sydney, NSW, Australia
Topic: Copper Dyshomeostasis and Neurodegenerative Disease
Topic: Copper Dyshomeostasis and Neurodegenerative Disease
Dr. Louis C. Penning
Faculty of Veterinary Sciences, Utrecht University, Utrecht, The Netherlands
Topic: The Copper-Lipid Droplet Connection
Topic: The Copper-Lipid Droplet Connection
Dr. Carmen Espinos
• Department of Genetics, Universitat de Valencia; Joint Unit CIPF-INCLIVA; CIBER on rare diseases (CIBERER), Valencia, Spain.
• Chairwoman of AITER (a consortium of 15 institutions dedicated to Translational Research in Rare Diseases in Valencia)
Topic: MicroRNAs and Wilson Disease
• Chairwoman of AITER (a consortium of 15 institutions dedicated to Translational Research in Rare Diseases in Valencia)
Topic: MicroRNAs and Wilson Disease
Programme
Programme
